19 May 2013
Keywords: fda, clears, imclone, bb50, production, unit, systems
Article | 01 December 2008
ImClone Systems, which is the subject of an agreed $6.5-billion takeover by US drug major Eli Lilly (Marketletter October 13), says ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 December 2008
17 May 2013
© 2013 thepharmaletter.com